Food allergy drug developer Alladapt raised $119M in new funding
June 22, 2022 at 18:52 PM EDT
The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|